Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MAESTRO Study: Metabolic Imaging to Improve Patient-Specific Therapy Outcomes

NCT04534543 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.

NCT NCT04534543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04534543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MAESTRO Study: Metabolic Imaging to Improve Patient-Specific Therapy Outcomes
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase
Not applicable
Overall status
Recruiting
Start date
December 15, 2021
Completion date
February 1, 2027
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancer metastatic